“The current scenario has uncovered some structural weaknesses within the EU’s medicines supply chain plus a significant dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides reported. She advised that offer chain troubles be resolved in an EU pharmaceutical approach anticipated to get launched by th